What’s Instore For Big Pharma In 2017?

What's Instore For Big Pharma In 2017?

The US pharmaceutical industry has had a tough 2016, and according to Morgan Stanley, the outlook for the sector is no better next year.

Indeed, according to a lengthy report on the state of the pharmaceutical industry from Morgan, there are few catalysts for the sector’s growth next year and thanks to this the industry will be at the mercy of political decisions.

Saved Articles

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up for ValueWalkPremium today and get our exclusive content for 35% off.

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 11/30/2019 or after next 25 20 subscribers take advantage whichever comes first – please do not share this discount with others